CLHIA-ACCAP

CLHIA Report on Prescription Drug Policy

Issue link: http://clhia.uberflip.com/i/406567

Contents of this Issue

Navigation

Page 44 of 44

39 21. The CLHIA recommends that all pharmacy receipts in Canada clearly disclose the dispensing fee charged, as well as the pharmacy mark-up, in order to incent a greater degree of consumerism in the market. 22. The CLHIA recommends that there be a continued, thoughtful, expansion of the scope of practice for pharmacists and, in particular, that all provinces allow for therapeutic substitution by pharmacists with the minimum degree of administrative complexity. E. ENSURING ACCESS TO ORPHAN DRUGS 23. The CLHIA recommends that Governments lead the work towards creating a new end-to-end approval process for orphan drugs that will include not only a safety and effectiveness review but also establish an equitable and sustainable funding arrangement for such drugs and that the review process should include public and private payers, drug manufacturers, health care professionals, and patients groups.

Articles in this issue

view archives of CLHIA-ACCAP - CLHIA Report on Prescription Drug Policy